专利信息

查询条件展开筛选条件

[药品] 包含 'Gliclazide '

首页上页 1 2 3 4 5 6 7 8 下页尾页共 161 条记录, 当前第3/17页。

	公开号	公开日	申请号	申请日

首页上页 1 2 3 4 5 6 7 8 下页尾页共 161 条记录, 当前第3/17页。

当前查询条件: [药品] 包含 'Gliclazide '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN102584677A	2012/7/18	CN20121025914	2012/2/7
专利标题：A kind of preparation method of gliclazide b.p. 2000 专利权人：Anhui Jinding Pharmaceutical Co., Ltd.;

2. CN102557997A	2012/7/11	CN20121012306	2012/1/16
专利标题：A kind of preparation method of tolylsulfonylurea 专利权人：Jinan Ift Science & Technology Co., Ltd.;

3. EP2468268A1	2012/6/27	EP20110194832	2011/12/21
专利标题：Combination composition of vildagliptin and gliclazide 专利权人：SANOVEL ILAC SANAYI VE TICARET A S [TR]; The present invention relates to a combination composition, characterized by comprising particles containing vildagliptin or a pharmaceutically acceptable salt or polymorph of vildagliptin, and particles containing gliclazide or a pharmaceutically acceptable salt or polymorph of gliclazide.

4. EP2468267A1	2012/6/27	EP20110194806	2011/12/21
专利标题：Bilayer Combination Composition of Vildagliptin and Gliclazide 专利权人：SANOVEL ILAC SANAYI VE TICARET A S [TR]; The present invention relates to a combination composition comprising two or more layers, one layer of said composition comprising vildagliptin or a pharmaceutically acceptable salt or polymorph of vildagliptin, and the other layer of said composition comprising gliclazide or a pharmaceutically acceptable salt or polymorph of gliclazide. At least one film coating layer is provided in the composition, this layer providing a coating for each layer separately, or for the combined surfaces of said l...

5. CN102440972A	2012/5/9	CN20111276126	2011/9/16
专利标题：Gliclazide sheet (ii) and preparation method thereof 专利权人：Zhejiang Zhongyi Pharmaceutical Co.,ltd.;

6. WO2012039197A1	2012/3/29	WO2011JP67637	2011/8/2
专利标题：AGENT FOR ENHANCING TRAIL SENSITIVITY 专利权人：UNIV NIHON [JP];SUZUKI YOSHIHIRO [JP];OCHIAI TOYOKO [JP];SUZUKI MIKI [JP];INOUE TOSHIO [JP];RA CHISEI [JP]; In the present invention TRAIL resistance was overcome in a malignant tumor resistant to TRAIL. By using an agent for enhancing TRAIL sensitivity comprising, as an active ingredient, an ATP-sensitive potassium channel inhibitor such as gliclazide, glibenclamide, or U37883A, TRAIL resistance was overcome in a malignant tumor resistant to TRAIL.

7. CN102382034A	2012/3/21	CN20101278897	2010/9/6
专利标题：The compound method of a kind of n-amino-3-azabicyclo [3,3,0] octane hydrochloride 专利权人：Shandong Fangming Pharmaceutical Co., Ltd.;

8. CN101721392B	2012/2/8	CN20081152453	2008/10/24
专利标题：A kind of method for preparing of gliclazide slow release capsule 专利权人：

9. CN102028660B	2011/12/7	CN20101610259	2010/12/29
专利标题：A kind of gliclazide oral slow-release dry suspension and preparation method thereof 专利权人：Yangzhou Zhongbao Pharmaceutical Co., Ltd.;

10. CN101647785B	2011/12/7	CN20081118378	2008/8/15
专利标题：Gliclazide sustained-release tablet and preparation method thereof 专利权人：Beijing Cosci Med-tech Co., Ltd.;

下载范围

下载内容